RYAH Group and OMNI Medical Services Announce Collaboration for Clinical Study in Cannabis for Treatment of COVID-19
\”RYAH Group Secures Medical Device Certification for RYAH Smart Inhaler and Software\”
\”RYAH Group Secures Medical Device Certification for RYAH Smart Inhaler and Software\”
April is Parkinson\’s Disease Awareness Month. According to the Parkinson\’s Foundation, there are more than one million people living with the disease in the US alone. In addition, reports from Blue Cross Blue Shield indicate that prevalence rates of the disease are increasing, perhaps by more than 50 percent over a five-year period. As of …
Cannabis for Parkinson’s: Time to Take it Seriously? Read More »
Cannabis for glaucoma first made headlines in the 1970s, when there weren’t a lot of appealing medications on the market. At the time, cannabis promised fewer side effects and an impressive ability to reduce intraocular pressure (IOP). Now, half a century later, there has been considerable research into what THC can do for IOP, but …
The American legal landscape is changing. There are now just 14 states that still prohibit medical and adult-use cannabis. But, heading into 2022, many of these lingering holdouts have legislation or ballot initiatives on the table for the coming year. What states are likely to open up to medical cannabis in the coming months? …
2022 Predictions for Medical Cannabis Legislation in the US Read More »
The evidence supporting medical cannabis for the side effects of cancer treatments is well established. But what about cannabis for treating cancer itself? Much of the research remains in very preliminary stages. But, there is an explosion of curiosity among cancer patients seeking alternative treatment, fueled mainly by online misinformation. Clearly, patients are …
Patients are Curious, But Can Cannabis Treat Cancer? Read More »
On the third anniversary of medical cannabis legalization in the UK, there are a total of three patients with a prescription through the public system. Many more patients receive cannabis-derived medications, including whole flower and cannabis oil, through a growing number of private clinics. Market analysts continue to place high hopes on the potential of …
3 Years In: An Update on Medical Cannabis in The UK Read More »
Colombia has become the darling of legalized cannabis in Latin America (LATAM). With medical cannabis, scientific study, and export legal in South America\’s northernmost country, expectations for the next decade are high. With a lush landscape ideally suited to outdoor cultivation, international cannabis producers have flocked to Colombia to expand and launch new endeavors. Its …
Colombia Becomes a Major Exporter, Continues Pro-Canna Evolution Read More »
Approximately four percent of American adults live with attention deficit hyperactivity disorder (ADHD). Typically diagnosed in childhood between the ages of three to six, this neurological disorder persists well into adulthood, with symptoms that make it difficult to focus, stay organized, and complete tasks. Many adults (sometimes beginning in early adolescence) manage the symptoms of …
In the ever-evolving world of global medical cannabis policy, Latin American countries don\’t always make the headlines. Yet, Brazil, one of the region\’s largest markets, is quietly, if incrementally, making advances toward a powerful medical cannabis program. Medical cannabis in Brazil may face some steep political hurdles, but the waves of reform are slowly making …
Past, Present, and Future: Medical Cannabis in Brazil Read More »